Towards clinical translation of biomarkers and therapies targeting autolysosomal acidification dysfunction in neuroinflammation and neurodegeneration—an interview with Prof. David Rubinsztein

Abstract

The article is an interview with Prof. David Rubinsztein, Department of Medical Genetics, and Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK, conducted by Dr. Chih Hung Lo, Dean’s Postdoctoral Fellow of Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore and an incoming Assistant Professor in the Department of Biology and Interdisciplinary Neuroscience Program at Syracuse University, USA, on behalf of Aging Pathobiology and Therapeutics.